{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:32:50Z","timestamp":1793305970021,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzhen Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118570","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:02:54Z","timestamp":1792738974000},"page":"118570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P4","title":["ZYX knockdown alleviates chemotherapy resistance in epithelial ovarian cancer"],"prefix":"10.1016","volume":"254","author":[{"given":"Xiangyun","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changtao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huainian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9574-515X","authenticated-orcid":false,"given":"Yongli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcp.2026.118570_b0005","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/cncr.35135","article-title":"Top advances of the year: ovarian cancer","volume":"130","author":"Lumish","year":"2024","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.118570_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010587","article-title":"Role of SLC7A11\/xCT in ovarian cancer","volume":"25","author":"Fantone","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118570_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102489","article-title":"Targeting NaPi2b in ovarian cancer","volume":"112","author":"Banerjee","year":"2023","journal-title":"Cancer Treat. Rev."},{"issue":"Pt 3","key":"10.1016\/j.bcp.2026.118570_b0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.semcancer.2022.03.027","article-title":"Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment","volume":"86","author":"Schoutrop","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118570_b0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/AOG.0000000000004173","article-title":"Updates and new options in advanced epithelial ovarian cancer treatment","volume":"137","author":"Kurnit","year":"2021","journal-title":"Obstet. Gynecol."},{"issue":"24","key":"10.1016\/j.bcp.2026.118570_b0030","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1158\/0008-5472.CAN-22-0455","article-title":"Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer","volume":"82","author":"Chambers","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118570_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.711020","article-title":"Integration of scRNA-seq and bulk RNA-Seq to analyse the heterogeneity of ovarian cancer immune cells and establish a molecular risk model","volume":"11","author":"Liang","year":"2021","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118570_b0040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/bjc.2016.203","article-title":"ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells","volume":"115","author":"Vaidyanathan","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.bcp.2026.118570_b0045","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.21873\/anticanres.14618","article-title":"The role of Zyxin in carcinogenesis","volume":"40","author":"Partynska","year":"2020","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.bcp.2026.118570_b0050","doi-asserted-by":"crossref","first-page":"15775","DOI":"10.1002\/jcp.28236","article-title":"Zyxin as a potential cancer prognostic marker promotes the proliferation and metastasis of colorectal cancer cells","volume":"234","author":"Zhong","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2026.118570_b0055","doi-asserted-by":"crossref","first-page":"11123","DOI":"10.1038\/ncomms11123","article-title":"Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-\u03b2 signalling pathways","volume":"7","author":"Ma","year":"2016","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2026.118570_b0060","doi-asserted-by":"crossref","first-page":"805","DOI":"10.32604\/or.2023.029549","article-title":"Zyxin promotes hepatocellular carcinoma progression via the activation of AKT\/mTOR signaling pathway","volume":"31","author":"Cai","year":"2023","journal-title":"Oncol. Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.118570_b0065","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1002\/mco2.357","article-title":"Zyxin inhibits the epithelial-mesenchymal transition process in gastric cancer by upregulating SIRT1","volume":"4","author":"Lou","year":"2023","journal-title":"MedComm (2020)"},{"issue":"6","key":"10.1016\/j.bcp.2026.118570_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/biom12060827","article-title":"Expression of Zyxin in non-small cell lung cancer-a preliminary study","volume":"12","author":"Partynska","year":"2022","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.bcp.2026.118570_b0075","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jprot.2011.11.005","article-title":"Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: a possible role for 14-3-3 theta\/tau and tBID?","volume":"75","author":"Hodgkinson","year":"2012","journal-title":"J. Proteomics"},{"issue":"5","key":"10.1016\/j.bcp.2026.118570_b0080","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jprot.2011.02.014","article-title":"Repeatedly identified differentially expressed proteins (RIDEPs) from antibody microarray proteomic analysis","volume":"74","author":"Hodgkinson","year":"2011","journal-title":"J. Proteomics"},{"issue":"2","key":"10.1016\/j.bcp.2026.118570_b0085","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.canlet.2012.12.019","article-title":"Zyxin cooperates with PTOV1 to confer retinoic acid resistance by repressing RAR activity","volume":"331","author":"Youn","year":"2013","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.bcp.2026.118570_b0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3892\/ol.2024.14365","article-title":"Drug resistance\u2011related gene targets and molecular mechanisms in the A2780\/Taxol\u2011resistant epithelial ovarian cancer cell line","volume":"27","author":"Yang","year":"2024","journal-title":"Oncol. Lett."},{"issue":"23","key":"10.1016\/j.bcp.2026.118570_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239218","article-title":"Transcriptome remodeling in gradual development of inverse resistance between paclitaxel and cisplatin in ovarian cancer cells","volume":"21","author":"Szenajch","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118570_b0100","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9335440","article-title":"HSP90AB1 as the druggable target of maggot extract reverses cisplatin resistance in ovarian cancer","volume":"2023","author":"Wang","year":"2023","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118570_b0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13048-025-01808-x","article-title":"Research on the process and molecular mechanism of inhibiting serous ovarian cancer by PRTN3 and its inhibitor Sivelestat","volume":"18","author":"Zheng","year":"2025","journal-title":"J. Ovarian Res."},{"issue":"21","key":"10.1016\/j.bcp.2026.118570_b0110","article-title":"Paclitaxel induces the apoptosis of prostate cancer cells via ROS-mediated HIF-1\u03b1 expression","volume":"27","author":"Zhang","year":"2022","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bcp.2026.118570_b0115","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s11626-023-00823-w","article-title":"Downregulation of BUBR1 regulates the proliferation and cell cycle of breast cancer cells and increases the sensitivity of cells to cisplatin","volume":"59","author":"Lu","year":"2023","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"issue":"14","key":"10.1016\/j.bcp.2026.118570_b0120","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.7150\/ijms.61944","article-title":"p53-dependent apoptosis is essential for the antitumor effect of paclitaxel response to DNA damage in papillary thyroid carcinoma","volume":"18","author":"Wu","year":"2021","journal-title":"Int. J. Med. Sci."},{"issue":"22","key":"10.1016\/j.bcp.2026.118570_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28227517","article-title":"Research advances in clinical applications, anticancer mechanism, total chemical synthesis, semi-synthesis and biosynthesis of paclitaxel","volume":"28","author":"Zhang","year":"2023","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bcp.2026.118570_b0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.tcb.2014.04.009","article-title":"LIM proteins in actin cytoskeleton mechanoresponse","volume":"24","author":"Smith","year":"2014","journal-title":"Trends Cell Biol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118570_b0135","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00404-020-05858-y","article-title":"Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells","volume":"303","author":"Dai","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1","key":"10.1016\/j.bcp.2026.118570_b0140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11033-024-09422-8","article-title":"Anti-cancer effects of alpha lipoic acid, cisplatin and paclitaxel combination in the OVCAR-3 ovarian adenocarcinoma cell line","volume":"51","author":"\u00c7oban","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2026.118570_b0145","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s13577-022-00744-y","article-title":"The EMT-activator ZEB1 is unrelated to platinum drug resistance in ovarian cancer but is predictive of survival","volume":"35","author":"Rae","year":"2022","journal-title":"Hum. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118570_b0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5937\/jomb0-38840","article-title":"EPS8L3 promotes pancreatic cancer proliferation and metastasis by activating GSK3B","volume":"42","author":"Fan","year":"2023","journal-title":"J. Med. Biochem."},{"issue":"11","key":"10.1016\/j.bcp.2026.118570_b0155","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41417-022-00489-8","article-title":"Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma","volume":"29","author":"Zhu","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bcp.2026.118570_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216653","article-title":"Glutamine transporter SLC38A3 promotes breast cancer metastasis via Gsk3\u03b2\/\u03b2-catenin\/EMT pathway","volume":"586","author":"Tan","year":"2024","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.bcp.2026.118570_b0165","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1080\/15384101.2022.2038847","article-title":"Phosphorylation of small kinetochore-associated protein induced by GSK3\u03b2 promotes cell migration and invasion in esophageal cancer","volume":"21","author":"Qin","year":"2022","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.bcp.2026.118570_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118659","article-title":"GSK-3\u03b2 in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer","volume":"1867","author":"Lin","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.bcp.2026.118570_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100779","article-title":"GSK3\u03b2 as a novel promising target to overcome chemoresistance in pancreatic cancer","volume":"58","author":"Pecoraro","year":"2021","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"10.1016\/j.bcp.2026.118570_b0180","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2020.07.005","article-title":"Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model","volume":"159","author":"Taylan","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118570_b0185","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14513","article-title":"Systematic profiling of Taxol resistance and sensitivity to tubulin missence mutations at molecular and cellular levels","volume":"103","author":"Zhou","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bcp.2026.118570_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2023.108503","article-title":"Computational analysis of drug resistance of taxanes bound to human \u03b2-tubulin mutant (D26E)","volume":"123","author":"Uba","year":"2023","journal-title":"J. Mol. Graph. Model."},{"issue":"5","key":"10.1016\/j.bcp.2026.118570_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051656","article-title":"Beta3-tubulin is critical for microtubule dynamics, cell cycle regulation, and spontaneous release of microvesicles in human malignant melanoma cells (A375)","volume":"21","author":"Altonsy","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118570_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188607","article-title":"\u03b2III-tubulin overexpression in cancer: causes, consequences, and potential therapies","volume":"1876","author":"Kanakkanthara","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118570_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100742","article-title":"Taxanes in cancer treatment: activity, chemoresistance and its overcoming","volume":"54","author":"Mosca","year":"2021","journal-title":"Drug Resist. Updat."},{"issue":"5","key":"10.1016\/j.bcp.2026.118570_b0210","doi-asserted-by":"crossref","first-page":"645","DOI":"10.21873\/cgp.20287","article-title":"Paclitaxel impedes EGFR-mutated PC9 cell growth via reactive oxygen species-mediated DNA damage and EGFR\/PI3K\/AKT\/mTOR signaling pathway suppression","volume":"18","author":"Mohiuddin","year":"2021","journal-title":"Cancer Genomics Proteomics"},{"issue":"4","key":"10.1016\/j.bcp.2026.118570_b0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3892\/etm.2024.12449","article-title":"Paclitaxel mediates the PI3K\/AKT\/mTOR pathway to reduce proliferation of FLT3\u2011ITD(+) AML cells and promote apoptosis","volume":"27","author":"Su","year":"2024","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.bcp.2026.118570_b0220","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41374-019-0368-9","article-title":"Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme","volume":"100","author":"Wen","year":"2020","journal-title":"Lab. Invest."},{"issue":"12","key":"10.1016\/j.bcp.2026.118570_b0225","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41580-022-00508-4","article-title":"Biochemical and mechanical regulation of actin dynamics","volume":"23","author":"Lappalainen","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"18","key":"10.1016\/j.bcp.2026.118570_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189818","article-title":"The miR-133a, TPM4 and TAp63\u03b3 role in myocyte differentiation microfilament remodelling and colon cancer progression","volume":"22","author":"Caporali","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2026.118570_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11082314","article-title":"Zyxin inhibits the proliferation, migration, and invasion of osteosarcoma via rap1-mediated inhibition of the MEK\/ERK signaling pathway","volume":"11","author":"Wei","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bcp.2026.118570_b0240","first-page":"413","article-title":"Zyxin: a mechanotransductor to regulate gene expression","volume":"23","author":"Wang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118570_b0245","first-page":"240","article-title":"DNA methyltransferase inhibitor CDA-2 synergizes with high-dose thiotepa and paclitaxel in killing breast cancer stem cells","volume":"3","author":"Lu","year":"2011","journal-title":"Front. Biosci. (Elite Ed.)"},{"issue":"1","key":"10.1016\/j.bcp.2026.118570_b0250","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4049\/jimmunol.166.1.574","article-title":"CD11b\/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression","volume":"166","author":"Perera","year":"2001","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118570_b0255","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/09680519030090050501","article-title":"Molecular basis for lipopolysaccharide mimetic action of Taxol and flavolipin","volume":"9","author":"Kawasaki","year":"2003","journal-title":"J. Endotoxin Res."},{"issue":"35","key":"10.1016\/j.bcp.2026.118570_b0260","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1038\/sj.onc.1209498","article-title":"Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways","volume":"25","author":"Wang","year":"2006","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.bcp.2026.118570_b0265","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1111\/febs.13767","article-title":"Low doses of paclitaxel enhance liver metastasis of breast cancer cells in the mouse model","volume":"283","author":"Li","year":"2016","journal-title":"FEBS J."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226009135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226009135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:19:25Z","timestamp":1793305165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226009135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":53,"alternative-id":["S0006295226009135"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118570","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ZYX knockdown alleviates chemotherapy resistance in epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118570"}}